SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-057719
Filing Date
2018-11-08
Accepted
2018-11-08 14:15:25
Documents
2
Period of Report
2018-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1522
2 POA DOCUMENT poa.txt EX-24.3_816247 4129
  Complete submission text file 0001209191-18-057719.txt   7106
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Szela Mary T (Reporting) CIK: 0001410289 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37620 | Film No.: 181169247

Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations